Shaun Duffy is the CEO and Managing Director of Reset Mind Sciences, a company focused on the use of psychedelic medicines to treat mental health.

Shaun has overseen the establishment of Reset Mind Sciences and its entry into the field of psychedelics, including fully licensed and regulatory approved mushroom cultivation and Western Australia’s first psilocybin based clinical trial.

Shaun is a former Senior Managing Director of FTI Consulting as well as head of that firm’s Australian Strategic Communications practice and member of its Australian Leadership Group. He previously provided strategy consultancy and corporate advisory services to Reset Mind Sciences’ parent company, Little Green Pharma.

Prior to FTI Consulting, Shaun held roles as the head of investor relations for three ASX listed companies. Shaun is a Chartered Accountant and holds a Bachelor of Commerce from the University of Western Australia.